SV Health Investors
Présence
Dirigeants
Voir l'organigramme avec ses 30 principaux dirigeants
Biographies les plus recherchées chez SV Health Investors
- Eugene Hill, Chairman of the Board
- Mike Ross, Managing Partner, Biotechnology
- Brent Faduski, Chief Financial Officer, Chief Compliance Officer ...
Changements de dirigeants chez SV Health Investors
- Nikola Trbovic qui était Partner, Biotechnology, est promu Managing Partner, Biotechnology (publié le 8 janvier 2024).
- Jamil Beg, a rejoint l'entreprise comme Partner, Biotechnology (publié le 8 janvier 2024).
Créer une alerte
pour suivre les mouvements de dirigeants chez SV Health Investors.
Fond
SV Health Investors a 1 475 concurrents dont Lloyds Development Capital (Royaume—Uni), BlackRock (Etats—Unis) et WindRose Health Investors (Etats—Unis).
Actualités en fusion/acquisition en Fond.
- Abrdn Private Equity Opportunities Trust changera son nom en Patria Capital Partners. (publié le 30 avril 2024).
- HMC Capital a acquis StratCap (publié le 28 février 2024).
- Thomvest Ventures vient d'annoncer une levée de fonds de 250 millions de dollars. (publié le 17 janvier 2024).
Contacts en Fond
- Antonio Gracias - Founder, Chief Executive Officer and Chief Investment Officer chez Valor Equity Partners
- Mortimer Buckley - Chairman of the Board and Chief Executive Officer (retiring in Dec 2024) chez Vanguard
- Jean-Marc Arbaud - President and Chief Executive Officer of CDPQ Infra chez Caisse de Dépôt et Placement du Québec
Actualités
Derniers communiqués de presse par SV Health Investors
- Cerevance Adds $47 Million in Series B-1 Extension to Advance Robust Clinical Pipeline - SV Health Investors
- Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair - SV Health Investors
- Former SV Portfolio Company Deciphera acquired by Ono Pharmaceutical for $2.4B after biotech's Phase 3 win - SV Health Investors
- SV Biotech launches its inaugural ESG and Impact Report - SV Health Investors
- Cumulus Neuroscience Receives Innovate UK Small Business Research Initiative (SBRI) Grant Focused on Clinical Biomarker Tools and Technologies for Dementia - SV Health Investors
- UK dementia adviser [Ruth McKernan] wants half a million volunteers for clinical trials - SV Health Investors
- Dementia Discovery Fund Look Ahead: 2024 is shaping up to be another big year in the fight against dementia - SV Health Investors
- Nitrase Therapeutics Unveils Pioneering Antibody Candidate for Parkinson’s Disease Based on Nitration Discovery in Oral Presentation at the Alzheimer’s Disease and Parkinson’s Disease (AD/PD) Conference - SV Health Investors
- Prilenia Plans to Submit Marketing Authorization Application (MAA) in the EU for Pridopidine in Huntington’s Disease - SV Health Investors
- Cumulus Neuroscience Announces First Patient Enrolled in AccelADx Electroencephalogram (EEG) Study for Early Detection of Alzheimer's Dementia - SV Health Investors
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de SV Health Investors
- SV Health Investors sur Wikipédia, Google News & Yahoo Finance en 1-click
- SV Health Investors sur LinkedIn, Twitter & YouTube en 1-click
Entrer en contact
Contacter par email ses dirigeants dont Eugene Hill 
Appelez SV Health Investors au +44 207...
